[HTML][HTML] Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou… - …, 2017 - augusta.elsevierpure.com
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - europepmc.org
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
[PDF][PDF] Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - pdfs.semanticscholar.org
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
[HTML][HTML] Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - oncotarget.com
Abstract Yongmei Liu 1, 2,*, Lei Deng 1,*, Xiaojuan Zhou 1,*, Youling Gong 1, Yong Xu 1,
Lin Zhou 1, Jin Wan 1, Bingwen Zou 1, Yongsheng Wang 1, Jiang Zhu 1, Zhenyu Ding 1 …
Lin Zhou 1, Jin Wan 1, Bingwen Zou 1, Yongsheng Wang 1, Jiang Zhu 1, Zhenyu Ding 1 …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - hub.hku.hk
© Liu et al. Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has
intracranial activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal …
intracranial activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - oncotarget.com
Abstract Yongmei Liu 1, 2,*, Lei Deng 1,*, Xiaojuan Zhou 1,*, Youling Gong 1, Yong Xu 1,
Lin Zhou 1, Jin Wan 1, Bingwen Zou 1, Yongsheng Wang 1, Jiang Zhu 1, Zhenyu Ding 1 …
Lin Zhou 1, Jin Wan 1, Bingwen Zou 1, Yongsheng Wang 1, Jiang Zhu 1, Zhenyu Ding 1 …
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low …
Y Liu, L Deng, X Zhou, Y Gong, Y Xu, L Zhou, J Wan… - Oncotarget, 2017 - europepmc.org
Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …
activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain …